Linked e-resources
Details
Table of Contents
Intro; Contents; 1 Introduction; A Crossroads for Global Drug Policy?; A Public Criminology Approach; Structure of the Book; References; 2 Step One: Acknowledge the Failure of a War on Drugs Strategy and the Harm it has Caused; The Rise of Prohibition Based Drug Policy; The Emergence of a War on Drugs; Failure of War on Drugs; Unintended and Harmful Consequences: Consumer Countries; Unintended and Harmful Consequences: Producer Countries; The Endurance of a War on Drugs Approach; Policy Developments Arising from the Proliferation of New Psychoactive Substances (NPS)
International Drug Conventions and Official Drug Policy Discourse; Conclusion; References; 3 Step Two: Recognise the Primary Importance of Addressing the Harm That Stems From and is Associated With Drug Use and Drug Control Policies; A Harm Reduction Approach to Drug Policy; The Evolution and Limitations of Harm Reduction as an Alternative Strategy of Drug Control; Addressing the Harm That Arises from Social and Material Inequality; Addressing the Harm That Is Experienced by Drug Producing Countries and That Arises as a Result of Human Rights Abuses
How Prevalent Is the Concept of Harm Reduction in Existing Systems of Drug Control?; Harm Reduction's Narrow Global Reach; Portugal as an Isolated Example of National Drug Policy Grounded in Harm Reduction; Reference to Harm Reduction in Official International Drug Policy Documentation; Conclusion; References; 4 Step Three: Encourage the Development of Innovative Strategies of Drug Control; Room for Manoeuvre: Flexibility Within the International Drug Conventions; Variety and Innovation in Cannabis Control Around the Globe
The Not-for-Profit Collective Cultivation Model: Cannabis Clubs in Spain; Cannabis Use for Medical and Religious Purposes: The Jamaican Drug Law Amendment; A Partially Regulated Market: Coffeeshop Policy in the Netherlands; Fully Regulated Markets: US States and Uruguay; The Benefits of Diversity and Innovation in Drug Policy; Limitations to Drug Policy Innovation; Reform of the International Drug Policy Conventions; Conclusion; References; 5 Step Four: Ensure That Drug Policy Innovations are Evaluated, and Evidence on Their Effectiveness is Shared Widely; Evidence Based Policy
Evidence-Based Drug Policy; Cross-National Comparative Research and the Development of Metrics of Drug Policy Effectiveness; Policy Transfer and Lesson Drawing: Another Kind of Evidence; Conclusion; References; 6 Step Five: Broaden the Horizons of the Drug Policy Debate; Including the Global South; Including the Local Level; Including a Greater Variety of Potentially Harmful Substances; Including the Full Range of Drug Scene Developments; Conclusion; References; 7 Conclusion; Obstacles to Implementing More Effective Global Drug Policies; Nature of Global Drug Policy Change; References
International Drug Conventions and Official Drug Policy Discourse; Conclusion; References; 3 Step Two: Recognise the Primary Importance of Addressing the Harm That Stems From and is Associated With Drug Use and Drug Control Policies; A Harm Reduction Approach to Drug Policy; The Evolution and Limitations of Harm Reduction as an Alternative Strategy of Drug Control; Addressing the Harm That Arises from Social and Material Inequality; Addressing the Harm That Is Experienced by Drug Producing Countries and That Arises as a Result of Human Rights Abuses
How Prevalent Is the Concept of Harm Reduction in Existing Systems of Drug Control?; Harm Reduction's Narrow Global Reach; Portugal as an Isolated Example of National Drug Policy Grounded in Harm Reduction; Reference to Harm Reduction in Official International Drug Policy Documentation; Conclusion; References; 4 Step Three: Encourage the Development of Innovative Strategies of Drug Control; Room for Manoeuvre: Flexibility Within the International Drug Conventions; Variety and Innovation in Cannabis Control Around the Globe
The Not-for-Profit Collective Cultivation Model: Cannabis Clubs in Spain; Cannabis Use for Medical and Religious Purposes: The Jamaican Drug Law Amendment; A Partially Regulated Market: Coffeeshop Policy in the Netherlands; Fully Regulated Markets: US States and Uruguay; The Benefits of Diversity and Innovation in Drug Policy; Limitations to Drug Policy Innovation; Reform of the International Drug Policy Conventions; Conclusion; References; 5 Step Four: Ensure That Drug Policy Innovations are Evaluated, and Evidence on Their Effectiveness is Shared Widely; Evidence Based Policy
Evidence-Based Drug Policy; Cross-National Comparative Research and the Development of Metrics of Drug Policy Effectiveness; Policy Transfer and Lesson Drawing: Another Kind of Evidence; Conclusion; References; 6 Step Five: Broaden the Horizons of the Drug Policy Debate; Including the Global South; Including the Local Level; Including a Greater Variety of Potentially Harmful Substances; Including the Full Range of Drug Scene Developments; Conclusion; References; 7 Conclusion; Obstacles to Implementing More Effective Global Drug Policies; Nature of Global Drug Policy Change; References